G

Guanze Medical Information Industry (Holding) Co Ltd
HKEX:2427

Watchlist Manager
Guanze Medical Information Industry (Holding) Co Ltd
HKEX:2427
Watchlist
Price: 0.33 HKD Market Closed
Market Cap: 313.5m HKD

Profitability Summary

Guanze Medical Information Industry (Holding) Co Ltd's profitability score is 53/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score
53/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Guanze Medical Information Industry (Holding) Co Ltd

Revenue
155.7m CNY
Cost of Revenue
-93m CNY
Gross Profit
62.8m CNY
Operating Expenses
-35.8m CNY
Operating Income
27m CNY
Other Expenses
-9.8m CNY
Net Income
17.2m CNY

Margins Comparison
Guanze Medical Information Industry (Holding) Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Guanze Medical Information Industry (Holding) Co Ltd
HKEX:2427
313.5m HKD
40%
17%
11%
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR N/A N/A N/A
CA
Australian Goldfields Ltd
OTC:GRXXF
2.7T USD N/A N/A N/A
US
GE Vernova LLC
NYSE:GEV
133.2B USD
19%
3%
5%
US
China Industrial Group Inc
OTC:CIND
95.2B USD
16%
10%
9%
NL
Nepi Rockcastle NV
JSE:NRP
82B Zac
66%
62%
69%
US
CoreWeave Inc
NASDAQ:CRWV
71B USD
74%
10%
-44%
US
Coupang Inc
F:788
44.4B EUR
30%
2%
1%
IN
Vasundhara Rasayans Ltd
BSE:538634
3.3T INR
59%
16%
16%
ZA
Afine Investments Ltd
JSE:ANI
36.3B Zac
0%
91%
160%
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
538.4T IDR
49%
41%
18%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Guanze Medical Information Industry (Holding) Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Guanze Medical Information Industry (Holding) Co Ltd
HKEX:2427
313.5m HKD
7%
6%
11%
7%
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR N/A N/A N/A N/A
CA
Australian Goldfields Ltd
OTC:GRXXF
2.7T USD
-21%
-20%
-21%
-165%
US
GE Vernova LLC
NYSE:GEV
133.2B USD
22%
4%
6%
2%
US
China Industrial Group Inc
OTC:CIND
95.2B USD
39%
24%
37%
34%
NL
Nepi Rockcastle NV
JSE:NRP
82B Zac
13%
7%
7%
6%
US
CoreWeave Inc
NASDAQ:CRWV
71B USD
-42%
-6%
2%
2%
US
Coupang Inc
F:788
44.4B EUR
6%
2%
7%
4%
IN
Vasundhara Rasayans Ltd
BSE:538634
3.3T INR
17%
14%
18%
15%
ZA
Afine Investments Ltd
JSE:ANI
36.3B Zac
25%
18%
11%
10%
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
538.4T IDR
8%
3%
9%
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less